We represented Nordic Capital Fund VIII (Nordic Capital) as special healthcare counsel in its definitive agreement to become the new controlling shareholder of U.S. – based company eResearch Technology, Inc. (ERT). Terms of the transaction were not disclosed.
Nordic Capital Funds invest in companies in northern Europe and in selected investment opportunities internationally. Nordic Capital Fund VIII has EUR 3.5 billion in committed capital, principally provided by international institutional investors such as pension funds. ERT is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development.